MiR-132 inhibits expression of SIRT1 and induces pro-inflammatory processes of vascular endothelial inflammation through blockade of the SREBP-1c metabolic pathway.

Cardiovasc Drugs Ther 2014 Aug;28(4):303-11

Department of Cardiology, The first Affiliated Hospital of Chinese PLA General Hospital, Beijing, 100048, China.

Purpose: Inflammation participates centrally in all stages of atherosclerosis (AS), which begins with pro-inflammatory processes and inflammatory changes in the endothelium, related to lipid metabolism. MicroRNA (miRNA) inhibition of inflammation related to SIRT1 has been shown to be a promising therapeutic approach for AS. However, the mechanism of action is unknown.

Methods: We investigated whether miRNAs regulate the SIRT1 and its downstream SREBP-lipogenesis-cholesterogenesis metabolic pathway in human umbilical vein endothelial cells (HUVECs). HUVECs were transfected with miR-132 mimics and inhibitors, and then treated with or without tumor necrosis factor α (TNFα). The effects of miR-132 on pro-inflammatory processes, proliferation and apoptosis were assessed.

Results: We identified that the relative 3' UTR luciferase activities of SIRT1 were significantly decreased in miR-132 transfected HUVECs (0.338 ± 0.036) compared to control (P = 0.000). miR-132 inhibited SIRT1 expression of mRNA level in HUVECs (0.53 ± 0.06) (P < 0.01) as well as proteins of SIRT1. mRNA expression and protein levels of SREBP (0.45 ± 0.07), fatty acid synthase (FASN) (0.55 ± 0.09) and 3-hydroxy-3-methylglutaryl CoA reductase (HMGCR) (0.62 ± 0.08) (P < 0.01), which are downstream regulated genes, were reduced in HUVECs by miR-132. MiR-132 promoted pro-inflammatory processes and apoptosis of HUVECs induced by TNF-α, and inhibited its proliferation, viability and migration.

Conclusions: SIRT1 mRNAs are direct targets of miR-132. miR-132 controls lipogenesis and cholesterogenesis in HUVECs by inhibiting SIRT1 and SREBP-1c expression and their downstream regulated genes, including FASN and HMGCR. Inhibition of SIRT1 by miR-132 was associated with lipid metabolism-dependent pro-inflammatory processes in HUVECs. The newly identified miRNA, miR-132 represents a novel targeting mechanism for AS therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10557-014-6533-xDOI Listing
August 2014
43 Reads

Publication Analysis

Top Keywords

pro-inflammatory processes
12
metabolic pathway
8
mir-132
5
sirt1
5
huvecs
4
cells huvecs
4
transfected mir-132
4
huvecs transfected
4
huvecs huvecs
4
mimics inhibitors
4
necrosis factor
4
factor tnfα
4
tumor necrosis
4
treated tumor
4
endothelial cells
4
inhibitors treated
4
mir-132 mimics
4
umbilical vein
4
unknownmethods investigated
4
investigated mirnas
4

Altmetric Statistics

References

(Supplied by CrossRef)

Y Suárez et al.
Circ Res 2007

A Kuehbacher et al.
Circ Res 2007

TA Harris et al.
Proc Natl Acad Sci U S A 2008

JE Fish et al.
Dev Cell 2008

S Wang et al.
Dev Cell 2008

S Wang et al.
PNAS 2005

GA Wayman et al.
PNAS 2008

HY Cheng et al.
Neuron 2007

AS Nudelman et al.
Hippocampus 2010

JC Strum et al.
Mol Endocrinol 2009

MC Haigis et al.
Genes Dev 2006

Similar Publications